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Abstract
Background: Anxiety is among the most prevalent and disabling mental health problems in older adults. Few older
adults with mild to moderately severe anxiety symptoms receive adequate interventions, putting them at risk for
developing anxiety disorders, depression, and various somatic problems. Effective, low-threshold interventions
should be developed. Blended care, in which a web-based intervention is combined with a limited amount of
face-to-face contacts with a mental healthcare counselor at the general practice, is a promising option. The online
self-help intervention “Living to the Full”—an Acceptance and Commitment Therapy (ACT) intervention—has been
proven to reduce depression and anxiety in several patient groups, but has not yet been investigated in older adults.
The aim of this study is to evaluate the (cost-)effectiveness of a blended form of “Living to the Full” in reducing anxiety
symptoms in adults aged 55 to 75 years. Furthermore, moderators and mediators of the treatment effect are investigated.
Methods/design: The (cost-)effectiveness of the ACT intervention will be investigated in a cluster single-blind randomized
controlled trial (RCT). The blended intervention will be compared to treatment-as-usual. Thirty-six mental health counselors
working at general practices in the Netherlands will be randomized to deliver blended care or treatment as usual. A total of
240 participants (aged 55–75 years) with mild to moderately severe anxiety complaints (defined as a total score of 5–15 on
the GAD-7) will be recruited. There are four measurements consisting of online questionnaires (primary outcome: GAD-7)
and a telephone interview: before the start of the intervention; directly following the intervention (14 weeks after baseline);
and six and twelve months after baseline. Possible mediator variables will be assessed multiple times basis during the
intervention.
Discussion: This RCT will evaluate the effectiveness of a blended ACT intervention for older adults with anxiety symptoms.
If the intervention is shown to be effective, it will be implemented, thereby improving the accessibility
and quality of preventive interventions for older adults with anxiety problems.
Trial registration: Netherlands Trial Register, NTR6270. Registered on 21 March 2017.
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Background
Anxiety problems form one of the most ubiquitous and
disabling mental health conditions in older adults. Preva-
lence estimates of anxiety disorders in this age group are
in the range of 1.2–14% [1, 2] . Furthermore, prevalence
studies on anxiety in older adults consistently show that
subclinical anxiety is even more widespread, with esti-
mates in the range of 15–52.3% in community samples.
These findings suggest that anxiety mostly presents as a
sub-threshold disorder in elderly adults [1, 2]. Unfortu-
nately, anxiety symptoms (and anxiety disorders as well)
frequently go unrecognized and untreated in older adults
[1–3]. This is due to several characteristics of this age
group such as a stronger belief in self-reliance, higher per-
ceived stigma of mental health problems, a limited willing-
ness to accept treatment for such problems, a tendency to
minimize symptoms, mobility problems, use of different
terms to describe psychological problems, and problems
with remembering and recognizing symptoms [4, 5]. Also,
it seems challenging for both clinicians and patients to dif-
ferentiate between functional and pathological anxiety in
older adults; anxiety in elderly adults is regularly consid-
ered to be an epiphenomenon of a physical condition or
part of the normal aging process [4, 6].
The fact that only a small proportion of anxious older
adults receive adequate treatment is alarming, since even
on a subclinical level, anxiety in older adults is associ-
ated with diminished quality of life and wellbeing [7, 8],
depressive symptoms, hypertension, urinary incontin-
ence [9], cognitive decline [10, 11], functional disability
[12], and an increased risk for stroke [13] and coronary
heart disease [14]. Furthermore, anxiety symptoms tend
to run a chronic course [7] and put people at risk for de-
veloping anxiety disorders [15]. To diminish the per-
sonal and societal impact of anxiety complaints in older
adults, low-threshold, evidence-based interventions are
needed [15, 16]. However, considering the high preva-
lence of anxiety symptoms in older adults and the rise in
life expectancy, even existing healthcare systems in afflu-
ent societies cannot adequately address this need.
Internet-based therapy (possibly combined with a lim-
ited amount of face-to-face contacts with a therapist,
counselor, or coach) is a promising option to reduce the
treatment gap in a cost-effective way. For older adults
with anxiety symptoms, Internet-based therapy could
lower some of the barriers that prevent them from seek-
ing help (e.g. perceived stigma on seeing a therapist, mo-
bility problems, strong belief in self-reliance with regard
to mental health).
In younger adult populations, Internet-based ther-
apy—predominantly cognitive behavioral interventions—
have repeatedly been shown to form a (cost-)effective
treatment option for both anxiety disorders and subclin-
ical anxiety [17–25]. Evidence so far suggests that a
combination of an online self-help module and therapist
support (either online, by telephone, or face-to-face) is
the most effective form of Internet-based therapy [25].
To date, only one study has examined an online interven-
tion for older adults with anxiety symptoms. This random-
ized controlled trial (RCT) found that Internet-delivered
cognitive behavioral therapy (CBT) was an efficacious and
cost-effective treatment for older adults with subclinical
anxiety [26]. The vast majority of other trials in anxious
older adults also focus on CBT but delivered as face-to-face
therapy to patients with anxiety disorders. Several
meta-analyses support the effectiveness of CBT for elderly
adults with an anxiety disorder [27–31]. However, re-
searchers suggest investigating other treatment approaches
as well, since the effect sizes for CBT in anxious older
adults are relatively small and several analyses suggest that
older adults benefit less from CBT for anxiety than the
younger adult population [2, 6, 28, 31, 32].
One treatment approach that might form a valuable al-
ternative for CBT in older adults is Acceptance and Com-
mitment Therapy (ACT), a so-called third-wave CBT [6,
33–35]. In contrast to CBT, ACT makes little to no use of
content-oriented cognitive techniques. The goal of ACT is
not to reduce the frequency or discomfort of negative in-
ternal experiences. Rather, ACT strives to reduce the
struggle that arises when people try to suppress internal
experiences and to stimulate people to engage in activities
that are meaningful to them. Ultimately, ACT aims to pro-
mote psychological flexibility: the ability to fully and
openly experience the present moment (including the
negative or painful aspects); and to persist in or change
behavior dependent on its accordance with personal goals
and values [33, 35, 36]. Meta-analyses support the effect-
iveness of ACT in reducing various psychological prob-
lems, including anxiety disorders [36–39]. Internet
interventions based on ACT have also been shown to be
effective for adults with depressive and anxiety symptoms
[40, 41]. No large-scale, controlled trials have yet been
conducted to evaluate ACT interventions for older adults.
However, it could be argued that the ACT approach might
particularly resonate with older adults, as it concurs with
the reorientation on important life values and associated
value-directed behavior change in this life phase [34, 35].
Furthermore, an acceptance-based coping style could be
especially valuable for older adults, because age-related
adversities such as loss of dear ones and declining health
might be most effectively coped with through an
acceptance-oriented style. Some evidence suggests that in
older adults, acceptance is associated with better emo-
tional wellbeing and quality of life [35, 42–44]. Another
possible benefit of ACT is its transdiagnostic approach,
since anxiety and depression are highly co-morbid in older
adults [1, 2, 45]. Some evidence suggests that co-morbid
depressive symptoms have a negative impact on treatment
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outcome in anxious older adults (when treated with CBT)
[46]. Therefore, a transdiagnostic treatment that focuses
on psychological factors that might underlie both anxiety
and depression is highly valuable.
Considering the need for evidence-based interventions
for older adults with subclinical anxiety and the plausible
suitability of ACT for this group, the proposed study aims
to evaluate the (cost-)effectiveness of an Internet-based
ACT intervention for older adults with anxiety complaints
in general practice. To promote compliance and reduce
dropout, this intervention is combined with a limited
amount of face-to-face contacts with the mental health
counselor at the general practice. This intervention will be
compared to optimized treatment-as-usual. In addition to
the analysis of the (cost-) effectiveness, moderators and
mediators of treatment effects will also be investigated in
the study. The current paper describes the research proto-
col for this study.
Methods/design
Design
The proposed study is a pragmatic cluster single-blind
RCT. In a clustered trial, the unit of randomization is not
the individual participant, but a group of participants (e.g.
patients from one general practice, students from the
same school, family members). In this study,
randomization takes place on the level of the mental
health counselors at general practices, which creates clus-
ters of participants that receive treatment from the same
counselor. Cluster randomization is used in this study to
reduce experimental contamination [47] and to minimize
administrative burden and time spent on training the par-
ticipating mental health counselors in the used treatment
methods. Participating mental health counselors will be
randomly assigned to one of the following two conditions:
they will either treat all included patients in their prac-
tice(s) with the Internet-based ACT intervention or pro-
vide all their patients with treatment-as-usual. In most
cases, randomization of the mental health counselor will
coincide with randomization of the practice(s) at which
he/she is employed, but some practices employ multiple
counselors. In these practices, a double randomization
procedure will be used. First, the counselors are random-
ized. Second, when patients of this practice are included
in the study, they are randomly allocated to one of the
counselors in the practice.
The randomization table (containing 36 cells, block ran-
domized into blocks of four cells) will be created by an in-
dependent researcher using R software. Participants,
mental health counselors, and the main researcher (who
serves as the contact person for the mental health coun-
selors) cannot be blind for allocation to conditions. How-
ever, participants are not informed on whether the
treatment they receive is the experimental or active
control intervention. They are told that the study aims to
compare two treatment options for people with mild to
moderate anxiety complaints. This is considered an ethic-
ally sound approach, since treatment-as-usual is delivered
as optimized care as usual.
Each participant will complete four main measure-
ments during the study: before the start of the interven-
tion (and before participants are informed about which
intervention they will receive) (T0); directly following
the intervention (three months after baseline; T1); and
six (T2) and twelve months (T3) after baseline. All mea-
surements consist mainly of online self-report question-
naires. T0, T1, and T3 also include a telephone
interview conducted by a research assistant. The re-
search assistant that conducts the telephone interviews
will be unaware of treatment allocation of the partici-
pants. If for any reason this blinding is broken, another
research assistant (that is blind to treatment condition of
the participant) will take over the telephonic assessment.
Figure 1 shows the flow chart of the study design. The
SPIRIT Checklist and Figure are presented as Additional
file 1 and 2 respectively. The study is approved by the
medical ethical committee of the Leiden University
Medical Center (LUMC; no. P16.248).
Participants
A total of 240 participants will be included. In order for a
person to be eligible to participate in the study, the follow-
ing inclusion criteria have to be met: aged 55–75 years;
presence of mild to moderate anxiety symptoms; access to
Internet; mastery of the Dutch language; and the possibil-
ity and motivation to spend up to 30 min per day on the
intervention. Potential individuals that meet any of the fol-
lowing exclusion criteria will be excluded from participa-
tion: Alzheimer’s disease or other severe cognitive
impairments; unstable severe medical condition(s); severe
anxiety or few anxiety symptoms; severe depressive symp-
tomatology; having received psychological or psychophar-
macological treatment (with the exception of stable use of
benzodiazepines or SSRIs) within the last three months;
severe role impairment in at least two areas of role func-
tioning; high suicide risk; substance use disorder or a life-
time diagnosis of bipolar disorder or schizophrenia. The
main inclusion criterion—severity of anxiety symptoms—
is measured with the GAD-7. This questionnaire uses
well-established cut-off points for mild, moderate, and se-
vere anxiety symptoms [48]. These cut-offs point are used
to identify our study population: people that score be-
tween 5 (cut-off point for mild anxiety) and 15 (cut-off
point for severe anxiety) are considered to experience mild
to moderately severe anxiety complaints. The information
in the participants’ medical record at the general practice
is used to determine the presence of a severe unstable
medical condition, severe cognitive impairment, and a
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lifetime diagnosis of bipolar disorder or schizophrenia..
The PHQ-9 [49] is used to assess depressive symptomol-
ogy (a score of ≥ 20 indicates severe symptoms and ex-
cludes people from participation). Role impairment is
assessed with the Sheeran Disability Scale (SDS) [50]. A
score of ≥ 8 on two of the three subscales is indicative of
severe role impairment. Participants are screened for high
suicide risk, substance use disorders, and a lifetime diag-
nosis of bipolar disorder or schizophrenia with the
M.I.N.I.-Plus [51].
Sample size
Cluster randomization will be applied at the level of the
participating mental health counselors. Assuming a mean
cluster size of five patients per counselor, an intraclass
correlation coefficient of 0.01 [52] and a coefficient of
variation of 0.30 [53], 18 mental health counselors in each
intervention arm and 90 participants per study arm are
needed to detect a between group difference on the
GAD-7 with a medium effect size (d = 0.45) with an alpha
of 0.05 (two-tailed) and a power of 0.80. Compensating
for an anticipated dropout of 25% (based on trials similar
to the proposed study with regard to either the treatment
approach [40, 54] or the study population [26]), 240 par-
ticipants will have to be included at baseline. The end-
point for this sample size is 14 weeks. In the most recent
and comprehensive Cochrane meta-analysis of 101 studies
of media-delivered CBT for anxiety disorders in adults,
Invitation/ information letters to
patients from participating general
practices
(estimated N = 20.000)
Screening for eligibility (online
self-report questionnaires)
Post-treatment assessment (T1)
      14 weeks after T0 (expected N = 180)
Online self-report questionnaires and
telephone interview
Screening for eligibility (clinical
telephone interview)
Informed consent and baseline
assessment (T0)
Randomization of 36 counselors 
Treatment-as-usual 
(N = 120)
Complete short questionnaire four
times during intervention
Web-based ACT intervention 
(N = 120)
Complete short questionnaire nine
times during intervention
First follow-up assessment (T2)
26 weeks after T0 (expected N = 168)
Online self-report questionnaires
Post-treatment assessment (T3)
52 weeks after T0 (expected N = 144)
Online self-report questionnaires and
telephone interview
Patients do not receive letter if: 
Age < 55 or > 75
Severe cognitive impairment
Unstable, severe medical condition
Exclusion:
GAD-7 score 5 < or > 15
PHQ-9 score > 20
No computer / Internet
Psychological treatment in past three
months
Non Dutch-speaking
Exclusion
High suicide risk
(History of) mania or psychosis
Substance use disorder
Severe role impairment
Use of psychiatric medication
Fig. 1 Diagram of patient flow through phases of the study
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moderate-quality evidence showed medium effect sizes
for CBT compared to control conditions (d = 0.67; 95%
confidence interval = 0.55–0.80) [23]. These effects were
somewhat smaller than those reported in other recent re-
views [17, 19–22] and also smaller than the large effect
sizes for Internet-based ACT (0.80 and 0.87) in the study
of Fledderus et al. [40] and for Internet-based CBT for
anxiety complaints in older adults (1.43) in the study of
Dear et al. [26]. These last two studies both compared
active treatment to a waiting list control condition. Fur-
thermore, Pots et al. reported an effect size of 0.41 for
web-based ACT (with e-mail support) compared to an
active control group (expressive writing) [41]. Based on
these studies, a moderate effect size of d = 0.45 is
estimated for the difference between the ACT online
intervention and treatment-as-usual.
Procedure
Recruitment of general practices
General practices will be recruited throughout the
Netherlands, with a focus on the Leiden and the Hague
area. Both general practitioners and the mental health
counselors working at the general practices will receive a
printed invitation to participate in the study, after which
they will be contacted by email and phone to recom-
mend participation. When a practice (both GP and men-
tal health counselor) agrees to participate, the mental
health counselor will be randomized. A total of 36 men-
tal health counselors will be included. Randomization is
performed by an independent researcher, who is in-
formed by the main researcher when a group of four
mental health counselors have been enrolled. The men-
tal health counselors are informed about their group al-
location by the main researcher and are invited to attend
a training in the treatment method they will apply dur-
ing the study.
Recruitment of participants
A data manager will visit the participating general prac-
tices to assist the general practitioner in the selection of
patients aged 55–75 years that are eligible to receive an
invitation letter for the study. Patients whose medical re-
cords mention a lifetime diagnosis of bipolar disorder or
schizophrenia, a severe unstable medical condition, Alz-
heimer’s disease, or other severe cognitive impairments
will not receive an invitation. All other patients aged
55–75 years do receive an invitation letter. The invita-
tion letter from the GP to the patients contains informa-
tion about anxiety complaints and explains the aim,
design, and procedure of the study. Furthermore, the let-
ter refers to the study website. On this website, potential
participants can read more extensive information about
the study and indicate their interest to participate. After
doing so, they will be asked to fill in the GAD-7 and
PHQ-9 and to indicate whether they have received psy-
chological treatment for emotional problems during the
last three months, have Internet access, have sufficient
time for treatment, are able to communicate in Dutch,
and are aged 55–75 years. If based on these answers pa-
tients are still eligible to participate, they are asked if
they are willing to be interviewed by phone to determine
whether they fulfill all inclusion criteria. They are asked
to fill in their telephone number and to indicate on
which day they prefer to be called. Within ten days they
will be phoned by a research assistant, who will adminis-
ter the SDS and M.I.N.I.-Plus. Furthermore, they will be
asked about their medication use. Patients will also be
given the opportunity to ask any remaining questions
about the aim of the study and the study procedures.
The interviewer will discuss his/her diagnostic findings
from the M.I.N.I-Plus with a senior clinical psychologist;
subsequently the interviewee is informed by mail about
inclusion or exclusion. When patients are eligible, they
will receive a link to an online informed consent form
and the baseline questionnaires (T0). Ineligible patients
will be referred to their general practitioner in case they
want help for their complaints. Once eligible patients
have filled in the informed consent form and the base-
line questionnaires, the mental health counselor at their
general practice will be informed about study participa-
tion and they will be invited for a first appointment. In
addition to the mass mailing, general practitioners and
mental health counselors will recommend participation
to patients aged 55–75 years that attend the practice
with anxiety complaints during the inclusion period.
They will inform these patients about the study and refer
them to the study website if they want to participate.
These patients then follow the screening and inclusion
procedure as described above.
Procedure during study participation
During the intervention, participants will fill in a short
questionnaire assessing potential mediator variables sev-
eral times. At these moments they will also complete the
GAD-2 [55] and PHQ-2 [56] to measure respectively anx-
iety and depression symptoms (the combination of
PHQ-2 and GAD-2 is also known as the PHQ-4 [57]).
They will also be asked whether they have had recurrent
thoughts about death or hurting themselves in the past
week, using an item of the PHQ-9 [49]. When participants
have had suicidal thoughts in the past week, they will be
recommended to discuss this with their mental health
counselor at the general practice. Furthermore, their men-
tal health counselor will be notified about the presence of
suicidal thoughts by the researchers and are asked to con-
tact the participant. Participants in the experimental con-
dition complete this questionnaire at the end of every
online lesson (nine times in total). Participants in the
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control condition, receive an email with a link to this
questionnaire after every session with the mental health
counselor (a total of four times).
Both interventions are delivered in a timespan of max-
imum 12 weeks, after which participants receive an
e-mail with a link to the online self-report question-
naires of the post-treatment assessment (T1). T1 also in-
cludes a clinical interview by telephone conducted by a
research assistant. The follow-up assessments take place
six (T2) and twelve months (T3) after baseline. Both
these assessments consist of self-report questionnaires
and T3 also includes a clinical telephone interview.
Figure 1 shows an overview of the patient flow through
the phases of the study.
Prevention of attrition
Although available research shows that the effect of eHealth
interventions does not depend on age and that older adults
are even more adherent than younger adults [58], several
precautions will be taken to reduce dropout and heighten
compliance throughout this study. If participants fail to
complete study assessments or intervention assessments,
motivational reminders will be send repeatedly by email.
Furthermore, individuals who complete all study assess-
ments will take part in a lottery for gift vouchers worth €50,
in order to stimulate them to complete all study assess-
ments (lotteries will take place every year during the data
collection period). If participants drop out or stop using the
intervention, they will be asked for the reason(s) why they
decided to quit the intervention and/or study.
Treatments
Experimental condition
The online intervention “Living to the Full” is an adaptation
of the similarly titled ACT-based self-help book [59] (Eng-
lish version: [60]). The effectiveness of this web-based inter-
vention (both with and without support from a counselor)
in reducing depression and associated anxiety in adults has
been established in RCTs [21, 40, 41, 61]. A pilot study in
which ten older adults worked through the online module,
resulted in some age-matched adaptations of the layout and
text of the intervention. The online module consists of nine
lessons that are ideally completed in a maximum of 12
weeks. The lessons are based on the six core processes of
ACT that aim to promote psychological flexibility: accept-
ance; cognitive defusion; contact with the present moment;
self as context; values; and committed action. Each lesson
contains information in both text and video form about the
relationship between the ACT processes and emotional
wellbeing, experiential exercises, metaphors, and motiv-
ational exercises. Furthermore, participants are instructed
to practice mindfulness for 10–15 min on a daily basis. The
intervention provides them with audio files that guide them
through the mindfulness exercises. Each week, participants
receive two or three standardized motivational text mes-
sages, to increase motivation and adherence. In addition to
the online self-help module, participants will have four
face-to-face sessions with the mental health counselor at
their general practice to increase motivation, evaluate their
progress, and discuss problems. For these sessions, a proto-
col has been developed. To measure adherence to the
protocol, mental health counselors will complete a short
online questionnaire after every face-to-face session which
asks them to give a brief summary of the session. The men-
tal health counselors in this condition will receive training
from an experienced clinical psychologist to get acquainted
with ACT, the protocol, and the online environment in
which their patients will be working. During the study, the
mental health counselors will have two supervision sessions
from a clinical psychologist.
Control condition
Treatment as usual will be provided as optimized care as
usual. Participants will be offered four face-to-face ses-
sions with the mental health counselor at the general
practice. The treatment follows the guideline for anxiety
complaints as developed by the Dutch College of General
Practitioners. This guideline prescribes psycho-education
and, if necessary, short-term CBT or problem-solving
therapy. A manual for the treatment older adults with
anxiety complaints has been developed by the researchers.
The manual comprises 12 small interventions. Each inter-
vention focuses on either a common form of anxiety
(worrying, panic symptoms, social anxiety), cognitive or
behavioral aspects typical of most anxiety complaints
(catastrophic thinking, avoidance), or consequences of
anxiety (sleeping problems, physical tension). All interven-
tions consist of psycho-educative texts and exercises based
on CBT. During the first session, the mental health
counselor and participant make an overview of the psy-
chological complaints of the participant. Based on this in-
ventory, one or more of the small interventions are
selected to form the basis of the next three sessions. In
order to prevent treatment diffusion, the delivery of inter-
ventions resembling the web-based interventions (i.e.
eHealth interventions in general and ACT and
mindfulness-based interventions in particular) are not
allowed. Mental health counselors will complete a short
online questionnaire that measures treatment protocol ad-
herence after every session. Mental health counselors in
this condition will follow a training from an experienced
clinical psychologist, to practice with the protocol. They
will also be supervised during the study.
Assessments
Table 1 depicts an overview of the assessment instru-
ments that will be used throughout the study. All ques-
tionnaires—except for the M.I.N.I.-Plus and SDS—will
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be conducted online. The M.I.N.I.-Plus and SDS are
conducted by telephone.
Primary outcome
Anxiety symptom severity
The primary outcome—severity of anxiety symptoms—
will be assessed with the GAD-7 [48]. This questionnaire
will be used to screen participants on anxiety symptoms
and to measure change in these symptoms from baseline
to post- and follow-up tests. The primary endpoint for
this measure is the measurement 14 weeks after baseline
(T1). The GAD-7 consists of seven items that are rated
on a 4-point scale ranging from 0 (not at all) to 3 (nearly
every day), e.g. “Over the last 2 weeks, how often have
you been bothered by: feeling nervous, anxious or on
edge.” Higher scores indicate more anxiety symptoms.
Total scores are in the range of 0–21 and scores of 5,
10, and 15 are taken as the cut-off points for mild, mod-
erate, and severe anxiety. Psychometric properties of the
GAD-7 are adequate and the scale may also be used as a
screener for panic disorder, social anxiety, and
post-traumatic stress disorder [48, 55, 62]. The reliability
Table 1 Overview of assessments during the study
Assessment Screening T0
Baseline
During intervention T1
Post-intervention
(14 weeks after T0)
T2
Follow-up
(26 weeks after T0)
T3 Follow-up
(52 weeks after T0)
GAD-7 X X – X X X
PHQ-9 X X – X X X
PHQ-4
(GAD-2 +
PHQ-2)
– – X – –
M.I.N.I.-Plus X – – X – X
SDS X – – X – X
CERQ – X – X X X
AAQ-II – X – X X X
MHC-SF – X – X X X
FFMQ-SF – X – X X X
EQ-5D-5 L – X – X X X
TIC-P – X – – X X
CSQ-8 – – – X – –
Self-esteem,
Mastery and
Support
– X – – – –
Life events – X – – – –
Somatic
problems
– X – – – –
Demographics
and other
information
– X – – – –
Treatment
credibility and
expectancy
– – X – – –
Emotion
regulation
– X X X X X
Behavioral
avoidance
– X X X X X
Treatment
expectancy
– – X – – –
Self-efficacy – – X – – –
SRS – – X – – –
GAD-7 General Anxiety Disorder 7, PHQ-9 Patient Health Questionnaire 9, PHQ-4 Patient Health Questionnaire 4,GAD-2 General Anxiety Disorder 2, PHQ-2 Patient
Health Questionnaire 2, M.I.N.I.-PLUS, Mini-International Neuropsychiatric Interview-PLUS, SDS Sheehan Disability Scale, CERQ Cognitive Emotion Regulation
Questionnaire, AAQ-II Acceptance and Action Questionnaire II, MHC-SF Mental Health Continuum Short Form, FFMQ-SF Five Facet Mindfulness Questionnaire Short
Form, EQ-5D-5 L EuroQol 5 dimensions 5 levels questionnaire, TiC-P Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness, CSQ-8 Client
Satisfaction Questionnaire 8, SRS Session Rating Scale
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and validity of a web-based Dutch translation of the
GAD-7 have also been established [63].
Furthermore, during treatment, participants will fill in
the GAD-2 [55] several times to measure anxiety symp-
tom severity. The GAD-2 consists of the first two items
of the GAD-7, which reflect core anxiety symptoms
(“Feeling nervous, anxious, or on edge” and “Not being
able to stop or control worrying”). Scores on the GAD-2
will be used in the mediation analyses. The GAD-2 is a
reliable, valid, and sufficiently sensitive and specific in-
strument [55, 63, 64].
Secondary outcomes
Depression symptom severity
Depression symptoms will be measured with the PHQ-9
[49]. This questionnaire will be used as a screener for
depressive symptoms and to measure change in depres-
sive symptomology from baseline to post- and follow-up
tests. The questionnaire consists of nine items and in-
cludes the DSM-IV criteria for a major depressive dis-
order. The items are rated on a 4-point scale ranging
from 0 (not at all) to 3 (nearly every day). Scores are in
the range of 0–27 and cut-off points of 5, 10, 15, and 20
represent mild, moderate, moderately severe, and severe
levels of depressive symptoms. The PHQ-9 is sensitive
to change, has good sensitivity and specificity for detect-
ing depressive disorders, and its psychometric properties
are adequate [62, 64, 65]. In addition, depression symp-
toms will be measured with the PHQ-2 [56] at several
times during treatment. The two items of the PHQ-2
(which correspond to the first two items of the PHQ-9)
measure core depressive symptomology. The scores on
these items will be used in the mediation analyses. The
reliability, validity, and sensitivity to change of the
PHQ-2 have been established [56, 57, 64].
Presence of psychiatric disorder
Presence of current and/or lifetime diagnosis of anxiety dis-
order (generalized anxiety disorder, panic disorder, agora-
phobia, specific phobia, social phobia), obsessive-compulsive
disorder, depressive disorder, post-traumatic stress disorder,
and illness anxiety disorder will be determined by the
M.I.N.I.-Plus [51]. Current substance abuse disorder and sui-
cide risk as well as a lifetime diagnosis of psychotic disorder
and bipolar disorder will also be assessed. The M.I.N.I.-Plus
is the most widely used psychiatric structured diagnostic
interview instrument in the world and has been validated
against the Structured Clinical Interview for DSM diagnoses
(SCID-P) and the Composite International Diagnostic Inter-
view for ICD-10 (CIDI) [51]. Trained research assistants
who are blind to the randomization scheme will conduct the
M.I.N.I-Plus by phone. The M.I.N.I.-Plus will be adminis-
tered during the screening (T0). At T1 and T3, only the
modules for current anxiety disorders, depressive disorder,
post-traumatic stress disorder, obsessive-compulsive dis-
order, and illness anxiety will be conducted. Minor adjust-
ments will be made to the M.I.N.I.-Plus, so it corresponds
with the criteria of the DSM-V. When uncertain of a diag-
nosis, the interviewers will have the opportunity to consult a
psychiatrist or senior clinical psychologist, who is also blind
to randomization status of the participants.
Functional impairment
The SDS [50] was developed to assess functional impair-
ment in three inter-related domains: work/school; social
life; and family life. The SDS measures the extent to
which work/school, social life, and home life or family
responsibilities are impaired by psychiatric symptoms on
a 10-point visual analogue scale. The three items can be
summed into a single dimensional measure of global
functional impairment that ranges from 0 (unimpaired)
to 30 (highly impaired). A psychometric analysis in a
large sample of primary care patients demonstrated that
the SDS has good psychometric qualities [50]. Research
assistants that are blind to group allocation, will admin-
ister the SDS by telephone during the screening (T0)
and at T1 and T3.
Cognitive emotion regulation
The subscales Rumination, Catastrophizing, Positive re-
appraisal, and Blaming yourself of the CERQ [66, 67]
will be used to measure the extent to which participants
use these cognitive coping strategies when confronted
with adversities. The choice for these subscales is based
on several studies that have demonstrated the associ-
ation between these strategies and anxiety and depres-
sion symptoms [67–69]. The subscales consist of four
items each. Higher scores on a subscale indicate that this
cognitive coping strategy is more often used to regulate
emotions. Psychometric properties of the Dutch CERQ
are adequate [68, 70].
Experiential avoidance
The Acceptance and Action Questionnaire (AAQ-II)
[71, 72] is a uni-dimensional measure [72, 73] that
assesses experiential avoidance: the unwillingness to
remain in contact with aversive private experience
and behaviors aimed at altering these experiences or
the events that elicit them. The AAQ-II originally
contained ten items, but a study showed that a
seven-item version has better psychometric qualities
[72]. Items are scored on a 7-point scale ranging
from 1 (never true) to 7 (always true). Higher scores
reflect higher levels of experiential avoidance. The re-
liability and validity of a Dutch translation of the
AAQ-II has been established in a sample of moder-
ately depressed and anxious individuals [73].
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Positive mental health
The Mental Health Continuum-Short Form (MHC-SF)
[74] is a 14-item self-report questionnaire for positive
mental health assessment. The questionnaire consists of
three subscales, corresponding with the three dimen-
sions of positive mental health: three items for emotional
wellbeing; six items for psychological wellbeing; and five
items for social wellbeing. Items are rated on a 6-point
scale ranging from 0 (never) to 5 (every day). Confirma-
tory factor analysis (CFA) confirmed the three-factor
structure of a Dutch translation of the MHC-SF. Results
from the same psychometric study also revealed high in-
ternal and moderate test–retest reliability for the Dutch
MHC-SF [74].
Mindfulness
The Five Facet Mindfulness Questionnaire- Short Form
(FFMQ-SF) [75] will be used to measure mindfulness,
defined as the ability to bring one’s attention to experi-
ences in the present moment in a non-judgmental way
[76]. The questionnaire contains 24 items that measure
five facets of mindfulness: observing; describing; acting
with awareness; non-judging; and non-reactivity. Items
are scored on a 5-point scale ranging from 1 (never or
very rarely true) to 5 (very often or always true). A psy-
chometric study showed that the FFMQ-SF is a sensitive,
reliable, and valid instrument. Furthermore, the
five-factor structure of the questionnaire was confirmed
in this study [75].
Generic health status and quality of life
The EuroQol-5 Dimensions-5 Levels questionnaire
(EQ-5D-5 L) measures general quality of life using five
dimensions (i.e. mobility, self-care, usual activities, pain/
discomfort, and anxiety/depression) [77]. Each dimen-
sion has five response categories, describing the severity
of problems. A total of 3125 unique health states can be
defined, by combining the responses for the five dimen-
sions into a five-digit number (ranging from “11111”
meaning no problems at all to “55555” meaning extreme
problems in all five dimensions) [78]. The EQ-5D-5 L is
an adaption of the EQ-5D [79]. The EQ-5D consists of
the same five dimensions but has only three response
categories per dimension. Evidence suggests that the
EQ-5D has limited responsiveness to changes in health,
partly caused by ceiling and floor effects. Studies show
that compared to the EQ-5D, the EQ-5D-5 L has smaller
ceiling and floor effects, and improved reliability and
discriminating ability [80, 81].
Costs associated with psychiatric illness
For calculating the total direct medical costs, the Trim-
bos/iMTA questionnaire for Costs associated with Psy-
chiatric Illness (TiC-P) [82] will be used. The TiC-P
measures utilization of medical treatment, such as the
number of contacts with the general practitioner and
multiple other care providers (e.g. medical specialists
and paramedics) during the last four weeks, as well as
medication use and loss of productivity at (voluntary)
work. The costs will be calculated using the Dutch
guidelines for cost calculations in healthcare. Reference
unit prices of the corresponding healthcare services will
be applied. A psychometric study demonstrated that the
Dutch version of the TIC-P is a feasible, reliable, and
valid tool for assessing care consumption and productiv-
ity loss in patients with mild to moderate psychiatric
problems [83].
Client satisfaction
The Client Satisfaction Questionnaire-8 (CSQ-8) [81] is
an eight-item instrument that is designed to measure cli-
ent satisfaction with services. The items for the CSQ-8
were selected based on mental health professionals’ rat-
ings of a number of items that could be related to client
satisfaction and a subsequent factor analysis. The CSQ-8
is uni-dimensional, yielding a homogeneous estimate of
general satisfaction with services. The questions are an-
swered on a 4-point scale in the range of 1–4, but each
question has different labels attached to these values.
Higher scores indicate higher client satisfaction. The
psychometric qualities of the Dutch translation of the
CSQ are adequate [84, 85].
Moderator variables
Self-esteem, mastery, and support
Starting from existing instruments, Bovier, Chamot, and
Perneger used factor analyses to develop four brief scales
for the assessment of self-esteem, affective social and
confident/problem-solving social support [86]. All 12
items are answered on a 5-point Likert scale, with higher
scores representing higher levels of the four measured
constructs. All four scales have been found to demon-
strate good internal and construct validity [86].
Life events
A self-developed questionnaire will be used to measure
negative life events and associated distress. Participants
are asked if they have experienced negative life events in
the past six months and/or earlier in their life. If they in-
dicate that they have experienced such (an) event(s),
they are asked to rate them on an 11-point scale (ran-
ging from 0 [not at all] to 10 [extremely]) to what extent
these experiences currently still evoke strong negative
feelings.
Co-morbid somatic problems
Co-morbid physical problems will be measured with a
self-developed questionnaire listing 25 (chronic)
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conditions. This list is based on information from Statis-
tics Netherlands. Participants will also be asked to rate
to what extent their somatic problem(s) interferes with
their current daily functioning on an 11-point scale ran-
ging from 0 (not at all) to 10 (extremely).
Socio-demographics and other information
Using a self-developed questionnaire, the following
socio-demographic information and additional informa-
tion will be collected: age; gender; nationality; marital
status; living conditions; education; work status; com-
puter usage; and Internet usage.
Treatment credibility and expectancies
Participants’ expectations of the treatment will be mea-
sured with a questionnaire derived from the Treatment
Credibility Questionnaire (TCQ) from Borkovec and
Nau [87]. In this study, the version as developed by De
Jong et al. (Risk models for negative treatment outcomes in
psychiatric outpatients: predicting end state functioning
and rate of change using classification and regression trees
(CART) and multilevel modeling, unpublished) will be
used. This version combines an adaptation of the TCQ [88]
with one item (“How much improvement in your symp-
toms do you think will occur”) from the Credibility Expect-
ancy Questionnaire [89]. The questionnaire consists of
seven items that are scored on a 7-point rating scale, ran-
ging from 1 (not at all) to 7 (extremely). The questionnaire
consists of two factors: Expectancies and Credibility. The
version that will be used in this study has an internal
consistency of 0.89 for the Expectancies subscale and 0.84
for the Credibility subscale [90]. This questionnaire will be
completed after participants have had the first session with
the mental health counselor at the general practice.
Mediator variables
Emotion regulation
A self-developed questionnaire measures the use of the fol-
lowing emotion regulation strategies: distraction; reappraisal;
acceptance; rumination/worry; and suppression. Adaptive
strategies (distraction, reappraisal, acceptance) are consist-
ently more strongly related with reduced negative affect and
maladaptive strategies (rumination/worry and suppression)
with enhanced negative affect in laboratory studies [91] and
psychopathology in clinical studies [92]. In addition, partici-
pants will be asked whether they used problem-solving and
attempted to change the stressful situation or contain its
consequences. Although problem-solving responses are not
directly aimed at regulating emotions, they can have benefi-
cial effects on emotions by modifying or eliminating
stressors [92]. Participants will report on the extent to which
they have engaged in each of these emotion-regulation strat-
egies on a 6-point scale ranging from 0 (never) to 6 (always).
The questionnaire consists of a total of seven items.
Behavioral avoidance
Since both interventions stimulate participants to limit
their avoidance behavior, this factor will be included in the
mediation analyses. Behavioral avoidance is measured with
one item (i.e. “In the past week my anxiety caused me to
avoid situations and/or activities”), that participants rate
on a 6-point-scale ranging from 0 (never) to 6 (always).
Treatment expectancy
Treatment expectancy is measured with one item: “How
confident are you that the course will be helpful in redu-
cing your anxiety complaints?” Participants rate this
question on a 7-point scale ranging from 1 (not at all) to
7 (very confident). Several studies have shown the im-
pact of client expectancies on treatment effect. Evidence
suggests that eliciting hope and positive expectations
about the effect of the treatment is a crucial factor in
many psychotherapies [93–96].
Self-efficacy
Preliminary results suggest that the outcome of psycho-
logical interventions may be mediated by patient’s
self-efficacy with regard to the treatment (i.e. one’s judgment
of the capability to successfully participate in and complete
the treatment) [97, 98]. Self-efficacy with regard to therapy
is measured with one item: “How confident are you that you
will do what is required to successfully follow and complete
this course?” Participants rate this question on a 7-point
scale ranging from 1 (not at all) to 7 (very confident).
Session Rating Scale
The Session Rating Scale (SRS) [99] will be used to measure
the working alliance between the participants and their men-
tal health counselor. The items assess four aspects of the
working alliance: the relational bond (the degree to which
one feels heard, understood, and respected); the degree to
which desired goals and topics of the individual were dis-
cussed; an evaluation of the therapist’s approach or method
that was used; and an evaluation of how the individual per-
ceives the session overall. Instead of using a visual analogue
scale, an 11-point scale will be used to answer each of the
four items, with “0” depicting the most negative response
and “10” depicting the most positive response. The SRS was
shown to have high test–retest and internal consistency reli-
ability, as well as acceptable validity [100, 101]. The SRS will
be completed after every face-to-face session.
Statistical analysis
All analyses will use intention-to-treat principles and a
two-tailed alpha of 0.05 for significance testing. Cluster
randomization at the level of mental health counselors
(instead of individual patients) results in a lack of inde-
pendence for the outcomes of patients receiving treat-
ment from the same counselor. If clustering and
Witlox et al. Trials  (2018) 19:502 Page 10 of 14
dependence of outcome are ignored, this could lead to
underestimation of standard errors and regression coef-
ficients [102]. Therefore, multilevel regression analysis
will be used to examine the treatment effect on the pri-
mary and secondary outcome measures. Multilevel ana-
lysis allows modeling of the variability of the outcome
measures within clusters and analysis of a
repeated-measure design with missing data. In this
cluster randomized RCT, three levels can be distin-
guished: (1) repeated measures within patients; (2)
treatment allocation; and (3) mental health counselors.
To evaluate the intervention effect, a twofold analysis
will be conducted. First, using a mixed-model analysis
with treatment as a dummy variable and the dependent
variable on baseline as covariate it will be examined
whether conditions differ across time. In addition, a
subsequent mixed-model analysis without the
dependent variable at baseline as covariate will analyze
at which particular time point conditions differ as indi-
cated by the interaction effect of treatment × time.
Missing data will be imputed using a model-based ap-
proach. Covariance will be estimated using an unstruc-
tured covariance matrix.
To examine moderators of the treatment outcome,
longitudinal multi-level regression analysis will be per-
formed. Potential moderators will be entered individu-
ally in the model. Interaction effects will be
investigated (e.g. time × condition × potential moder-
ator). Bivariate latent difference score models will be
used for the mediation analysis. This type of analysis is
recommended for repeated measurements and mul-
tiple mediators, because they allow for a more dynamic
approach to mediation, by assessing changes in multiple
variables and their interrelations over time [103–105].
Cost-effectiveness analyses will be conducted in agreement
with the CHEERS statement [106] and will be determined
by relating the difference in healthcare costs (measured
with the TiC-P) to the between-group difference in reliable
change on GAD-7 scores (cost-effectiveness analysis) and
quality-adjusted life-years (QALYs) gained based on the
EQ-5D-5 L using the Dutch tariffs (cost–utility analysis).
Productivity losses in paid work will be included in the eco-
nomic evaluation and measured by assessing work-loss days
due to absenteeism and work cutback days (presenteeism)
while at work but not feeling well. All cost prices will be
indexed for the appropriate reference year (likely to be
2017) but not discounted because the study’s time horizon
does not exceed the period of a single year. Stochastic un-
certainty in the incremental cost-effectiveness ratios
(ICERs) will be handled using non-parametric bootstraps
(2500 replications), plotted on the ICER plane and depicted
in an ICER acceptability curve. Sensitivity analyses will
focus on the friction cost versus human capital method and
on main cost-drivers.
Discussion
The proposed study will evaluate the (cost-)effectiveness
of the Internet-based ACT intervention ‘Living to the
Full’ for older adults with anxiety complaints in a RCT.
This study has several strengths. First, the trial is unique
in this field of research. It differs from the majority of
studies in older anxious adults with regard to therapy
approach (ACT instead of CBT), the delivery of the in-
vestigated intervention (Internet-based instead of
face-to-face) and the study population (people with anx-
iety complaints instead of anxiety disorders). The mod-
eration and mediation analyses form a second strength.
These analyses will provide insight into respectively the
effect of personal characteristics on treatment outcome
and the processes through which the intervention
achieves its effects. Including such analyses broadens the
scope of the study. The trial is not merely focused on
answering the question if “Living to the Full” is more or
less effective than treatment-as-usual. Because of the op-
timized active control condition, it is plausible that both
treatments will result in a significant reduction in symp-
tomology and related measures. In this scenario, the
moderation and mediation analyses will still be of value
in exploring if certain subgroups of patients benefit from
one of the interventions in particular and if the pro-
cesses through which the treatments achieved their ef-
fects differ. This sort of knowledge can contribute to a
more personalized treatment approach by taking into ac-
count moderating factors and an increased effectiveness
of interventions by refining and intensifying those com-
ponents that focus directly on the mediators [107]. An-
other strength of this study is related to the fact that
treatment-as-usual is delivered as optimized care as
usual. Because participants in the control condition will
receive appropriate treatment, a 12-month follow-up is
defendable, allowing to investigate the long-term (cost-)-
effectiveness of the “Living to the Full” intervention
compared to treatment as usual. A final strength of this
study is its recruitment method. All patients aged 55–75
years from participating general practices are actively in-
vited to participate in the study and are able to register
online. Compared to studies in which only patients that
visit their general practitioner with certain complaints
are informed about a study, this method reaches a wider
population and lowers the threshold for registering for
participation.
The study also has some limitations. First, the online
nature of the screening procedure and intervention
might limit the study sample. It excludes people that are
not proficient with computers. These people might share
certain characteristics (e.g. older age, lower education
levels), which reduces the representativeness of the sam-
ple. Second, the study might encounter difficulties in
recruiting enough participants. Recruiting older adults
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for study participation is challenging [108]. Furthermore,
due to the cluster-randomized design, more participants
are needed to obtain equivalent statistical power as com-
pared to an individually randomized trial [47]. However,
this study uses a mass mailing as the main recruitment
method, which has proven to be one of the most suc-
cessful strategies to recruit older adults [108].
To conclude, the proposed study will evaluate an ACT
online self-help program combined with face-to-face
contacts with the mental health counselor at the general
practice for older adults with anxiety symptoms. Since
subclinical anxiety is highly prevalent in this age group,
(cost-)effective, low-threshold interventions are needed.
The proposed study complies with this request. When
“Living to the Full” proves to be effective for this patient
group, implementation of the intervention in general
practices in the Netherlands will follow.
Trial status
Patient recruitment started November 2017. Recruit-
ment is expected to be completed December 2018.
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